Establishing the worth of deprescribing inappropriate medications: are we there yet?

Scott, Ian A; Reeve, Emily; Hilmer, Sarah N.

doi:10.5694/mja2.51686

Cited by 18 publications

(22 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…22 Although the benefits of deprescribing on health outcomes are uncertain, recent evidence suggests it is safe and feasible, 22,[37][38][39] with the caution that many deprescribing studies are of low quality with small participant numbers and short follow-up periods. 40…”

Section: Outcomes Of Deprescribingmentioning

confidence: 99%

Deprescribing considerations for older people in general practice

Quek¹,

Page²,

Potter³

et al. 2023

Aust J Gen Pract

View full text Add to dashboard Cite

show abstract

Section: Outcomes Of Deprescribingmentioning

confidence: 99%

Deprescribing considerations for older people in general practice

Quek¹,

Page²,

Potter³

et al. 2023

Aust J Gen Pract

View full text Add to dashboard Cite

show abstract

“…These studies have significantly increased our knowledge of what might work (as well as what does not work). 13 There is also increasing use of implementation science frameworks to explore how interventions can be improved to increase efficacy, and to support adaption for implementation in other settings and countries. Further research is required to establish the costeffectiveness of the interventions to influence policy makers and achieve sustained practice change.…”

Section: Fixing the Problem In The Real World: Interventional And Imp...mentioning

confidence: 99%

“…This may be due to insufficient sample sizes, small reductions in harmful medications, low uptake of advice, heterogeneity of treatment effects, insensitive outcome measures and more. These studies have significantly increased our knowledge of what might work (as well as what does not work) 13 . There is also increasing use of implementation science frameworks to explore how interventions can be improved to increase efficacy, and to support adaption for implementation in other settings and countries.…”

Section: Fixing the Problem In The Real World: Interventional And Imp...mentioning

confidence: 99%

The state of deprescribing research: How did we get here?

Reeve

Thompson

Boyd

et al. 2023

Basic Clin Pharma Tox

Self Cite

View full text Add to dashboard Cite

“…Similarly to Croatia, in the majority of European countries, proactive deprescribing policies, frameworks, and workflows are still being formed [ 13 ]. Evidence is being gathered on how to successfully identify the challenges of implementation of deprescribing across healthcare systems and settings [ 14 , 15 ], as well as how to enhance deprescribing interventions both in research and in everyday practice [ 16 , 17 ].…”

Section: Introductionmentioning

confidence: 99%

Differences in Factors Influencing Deprescribing between Primary Care Providers: Cross-Sectional Study

Bužančić

Hadžiabdić

2023

IJERPH

View full text Add to dashboard Cite

Deprescribing is a notable approach to improve medication management, but few healthcare systems recognize it. To introduce a new practice, it is important to examine the factors influencing the provision of a new or elaborate cognitive service within the desired setting. This study explores the perceived barriers and facilitators of deprescribing by primary healthcare providers, and identifies the factors associated with a willingness to suggest deprescribing. A cross-sectional survey was conducted (in Croatia, between October 2021 and January 2022) using a validated comprehensive healthcare providers’ opinions, preferences, and attitudes towards deprescribing (CHOPPED) questionnaire. A total of 419 pharmacists and 124 physicians participated. Participants showed a high willingness to deprescribe, with significantly higher scores in physicians than in pharmacists (5.00 (interquartile range—IQR 5–5) vs. 4.00 (IQR 4–5), p < 0.001). Pharmacists had significantly higher scores in seven out of ten factors (knowledge, awareness, collaboration facilitators, competencies facilitators, healthcare system facilitators, collaboration barriers, competencies barriers) while in the remaining three factors (patient facilitators, patient and healthcare system barriers) there was no difference in scores. The strongest positive correlation with willingness to suggest deprescribing was found with the collaboration and healthcare system facilitators factors for pharmacists (G = 0.331, p < 0.001, and G = 0.309, p < 0.001, respectively), and with knowledge, awareness, and patient facilitators factors for physicians (G = 0.446, p = 0.001; G = 0.771, p < 0.001; and G = 0.259, p = 0.043, respectively). Primary healthcare providers are willing to suggest deprescribing but face different barriers and facilitators. For pharmacists, the most important facilitators were extrinsic, while for physicians they were more intrinsic and patient related. The stated results provide target areas which one could focus upon to help to engage healthcare providers in deprescribing.

show abstract

Establishing the worth of deprescribing inappropriate medications: are we there yet?

Cited by 18 publications

References 25 publications

Deprescribing considerations for older people in general practice

Deprescribing considerations for older people in general practice

The state of deprescribing research: How did we get here?

Differences in Factors Influencing Deprescribing between Primary Care Providers: Cross-Sectional Study

Contact Info

Product

Resources

About